8-K: Zura Bio Appoints WithumSmith+Brown as New Independent Auditor Following Business Combination
Change of Auditor
Zura Bio Limited has engaged WithumSmith+Brown as its new independent auditor, replacing Marcum LLP, following the completion of a business combination.
Summary
- Zura Bio Limited has appointed WithumSmith+Brown, PC as their new independent registered public accounting firm, effective March 29, 2023.
- This change follows the business combination between Zura Bio Limited and JATT Acquisition Corp. on March 20, 2023.
- Marcum LLP, the previous auditor, was terminated as of the business combination date.
- Marcum's audit report for the period ending December 31, 2022, did not contain any adverse opinions or qualifications.
- There were no disagreements with Marcum regarding accounting principles or auditing procedures during their engagement.
- A material weakness in internal controls was identified by management related to complex financial instruments and the initial public offering proceeds.
- Zura Bio did not consult with Withum on any accounting or auditing matters prior to their engagement.
Sentiment
Score: 6
Explanation: The document primarily reports a procedural change in auditors following a merger, with a mention of a material weakness in internal controls. The change is expected, but the internal control issue is a concern.
Positives
- The previous auditor, Marcum LLP, issued a clean audit report for the period ending December 31, 2022, with no adverse opinions or qualifications.
- There were no disagreements with Marcum regarding accounting principles or auditing procedures during their engagement.
Negatives
- A material weakness in internal controls was identified by management related to the lack of ability to account for complex financial instruments and the improper accounting and reporting in the Company's historical financial statements of certain proceeds from the Company's initial public offering.
Risks
- The material weakness in internal controls related to complex financial instruments and the initial public offering proceeds could indicate potential issues with financial reporting.
- The change in auditors could lead to a period of adjustment and potential challenges in ensuring a smooth transition.
Industry Context
Changes in auditors are not uncommon following a business combination, as the newly formed entity often seeks to align its financial reporting practices with its new structure and goals.
Comparison to Industry Standards
- The engagement of a new auditor after a merger is a standard practice, similar to other companies undergoing significant structural changes.
- The identified material weakness in internal controls is not uncommon for companies that have recently gone public or undergone significant changes, but it is important to address it promptly.
- The lack of disagreements with the previous auditor is a positive sign, indicating a smooth transition in terms of accounting practices.
Stakeholder Impact
- Shareholders will be impacted by the change in auditors, as this is a key aspect of financial oversight.
- The identified material weakness in internal controls may raise concerns among investors.
Next Steps
- WithumSmith+Brown, PC will audit the company's consolidated financial statements for the year ending December 31, 2023.
Key Dates
| Date | Description |
|---|---|
| 2021-03-10 | Zura Bio Limited's inception date. |
| 2022-12-31 | End of the fiscal year for which Marcum LLP provided an audit report. |
| 2023-03-20 | Date of the business combination between Zura Bio Limited and JATT Acquisition Corp. |
| 2023-03-28 | Date of Marcum LLP's audit report. |
| 2023-03-29 | Date WithumSmith+Brown, PC was engaged as the new auditor and Marcum LLP was terminated. |
| 2024-02-23 | Date of the 8-K filing and Marcum's letter. |
Keywords
auditor, accounting, WithumSmith+Brown, Marcum, business combination, financial statements, internal controls, audit, Zura Bio
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.